GridAI Technologies (GRDX) Tax Provisions (2024)
GridAI Technologies' (GRDX) quarterly Tax Provisions came in at $4.3 million in Q2 2024, up 128.64% on a QoQ basis from -$14.9 million in Q1 2024.
GridAI Technologies (GRDX) Tax Provisions (2024) Analysis & Trends
GridAI Technologies (GRDX) has 1 years of Tax Provisions data on file, last reported at $4.3 million in Q2 2024.
- Quarterly Tax Provisions changed N/A year-over-year to $4.3 million in Q2 2024, while the trailing twelve-month figure through Sep 2024 was -$10.6 million (changed N/A YoY) and the FY2025 annual result came in at -$398736.0, changed N/A from the prior year.
- Tax Provisions grew to $4.3 million in Q2 2024, from -$14.9 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $4.3 million in Q2 2024 to a low of -$14.9 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 4.26 Mn |
| Mar 31, 2024 | -14.86 Mn |